RT Journal Article
SR Electronic
T1 Evolution in the pathological study of lung cancer
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 2918
DO 10.1183/13993003.congress-2020.2918
VO 56
IS suppl 64
A1 Alvaro Martinez Mesa
A1 Nuria Reina Marfil
A1 Eva Cabrera Cesar
A1 Ana Aguilar Galvez
A1 Esther Sanchez
A1 Maria Carmen Fernandez Aguirre
YR 2020
UL http://erj.ersjournals.com/content/56/suppl_64/2918.abstract
AB Introduction: The emergence of drugs against specific molecular biomarkers in lung cancer has led to the need for a more accurate diagnosis through obtaining better quality cytohistological samples. The objective of the study has been evaluated the pathological samples used for diagnosis of lung cancer and its histological type.Methods: A descriptive study of a random sample of 373 patients who were diagnosed with lung cancer in our hospital was performed. Demographic, clinical and pathological variables were recognized.Results: 77.21% (288) were male, with an average age of 66.74 years. 75.34% (288) were diagnosed by biopsy, obtained in 71.1% (200 samples) by pulmonologists (endobronchial or ultrasound-guided BAG). The most frequent cytological and histological diagnosis was non-small cell lung carcinoma and adenocarcinoma respectively. The diagnosis according to whether the sample obtained was cytological or histological is collected in Figures 1.The trend in the use of each type of sample over the years is represented in Figure 2.Conclusions: The shift to higher pathology samples is related to the increase in the therapeutic arsenal against lung cancer and a more personalized medicine.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 2918.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).